For the third consecutive year, the 探花直播 of Cambridge has broken its early stage investment record, approving 13 seed fund investments for a total of 拢3.8 million, an increase on the 拢3.2 million invested in 2013-14.
For the third consecutive year, the 探花直播 of Cambridge has broken its early stage investment record, approving 13 seed fund investments for a total of 拢3.8 million, an increase on the 拢3.2 million invested in 2013-14.
This record year for the 探花直播 of Cambridge Seed Funds is particularly pleasing since it underscores the immense emphasis that the 探花直播 places on innovation for the benefit of society across a wide range of scientific and technical endeavours
Nigel Slater
This new funding follows another successful year highlighted by the exit of X01 Limited, the developer of ichorcumab, an anticoagulant antibody with the potential to save millions of lives that was sold to Janssen Pharmaceuticals, Inc. During this period, the 探花直播 received 拢3.7 million from realised investments.
探花直播investment funds will move forward the progress of PhoreMost, a new-model drug discovery company that aims to develop drugs against targets previously thought to be 鈥榰ndruggable,鈥 Z-factor Limited, a drug discovery company created to identify and develop therapeutic agents to treat alpha-1-antitrypsin deficiency (one common manifestation of which is emphysema), Quethera, a gene therapy start-up developing a treatment for glaucoma that could prevent associated blindness, Cytora, a pioneer in the field of risk analysis technology and Reduse, whose cutting-edge 鈥榰nprinter鈥 technology removes print from paper, dramatically cutting C02 emissions compared to recycling by reducing the need for pulping, heating and chemicals.
鈥淭his record year for the 探花直播 of Cambridge Seed Funds is particularly pleasing since it underscores the immense emphasis that the 探花直播 places on innovation for the benefit of society across a wide range of scientific and technical endeavours,鈥 said Professor Nigel Slater, Pro-Vice-Chancellor for Enterprise and Regional Affairs.
, the 探花直播鈥檚 commercialisation arm, which is this year celebrating its 21st anniversary of 探花直播 investment, manages two evergreen seed funds on the 探花直播鈥檚 behalf. Cambridge Enterprise also advises the 探花直播 of Cambridge Enterprise Fund (UCEF), a combined Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) fund, which enables alumni and friends of the 探花直播 to support Cambridge spin-outs while benefitting from generous tax incentives.
This was the fourth year of operation for the Enterprise Fund, which was announced as part of the SEIS programme in the government鈥檚 2012 budget, established to stimulate economic growth. UCEF听III has invested 拢1.7 million across eight companies in a period of 18 months. 探花直播 探花直播 is raising its fourth Enterprise Fund in February.
In addition to the Enterprise Fund, the 探花直播 has approximately 拢16 million in seed funds available for investment. Through Cambridge Enterprise, the funds can provide pre-seed or seed funding.
Cambridge Enterprise Seed Funds provides links to management and sources of further funding. 探花直播 portfolio companies have gone on to raise more than 拢1.4 billion in follow-on funding.
探花直播text in this work is licensed under a . For image use please see separate credits above.
